4Liang H, Block T M, Wang M, et al. Interleukin-6 and on- costatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73 [J ]. Can- cer Bioroark, 2012, 11(4): 161.
5YANG Y. GP73 and AFP individual and joint the value of the diagnosis of primary liver cancer[J]. Chin J Lab Med, 2012, 35(11): 1034.
6Kawamoto S, Moriwaki K, Nakagawa T, et ai. Overexpres- sion of al, 6-fucosyltransferase in hepatoma enhances expres- sion of Golgi phosphoprotein 2 in a fucosylation-independent manner[Jl. IntJ Oncol, 2011, 39(1): 203.
7Norton P A, Comunale M A, Krakover J, et al. N-linked glycosylation of the liver cancer biomarker GP73 [J]. J Cell Biochem, 2008, 104(1): 136.
8RienerMO, Stenner F, L iewen H, et al. Golgi phosphopro- tein 2(GOLPH 2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas[J]. Hepatology, 2009, 49(5):1602-1609.
9Li X, Wu K, Fan D. Serum golgi phosphoprotein 2 level: a better marker than alpha fetoprotein for diagnosing eariy hepatocellular carcinoma[J]. Hepatology, 2009, 50(5):1652.
